Literature DB >> 19420858

Generation of vero cells expressing ebola virus glycoprotein.

Akiko Makino1, Yoshihiro Kawaoka.   

Abstract

To establish replication-incompetent Ebola virus (EBOV) lacking its glycoprotein (GP), we attempted to generate a Vero cell line that constitutively expressed GP. We used a retroviral vector to transduce Vero cells with the EBOV GP gene, resulting in a high expression level of GP on the cell surface. The Vero cells expressing EBOV GP complemented the replication cycle of vesicular stomatitis virus, which lacks the essential viral glycoprotein. This cell line might be useful for basic research on EBOV GP as well as for vaccine production.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19420858      PMCID: PMC6028927          DOI: 10.1292/jvms.71.505

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  13 in total

1.  Isolation of T-cell antigens by retrovirus-mediated expression cloning.

Authors:  T Kitamura; Y Morikawa
Journal:  Methods Mol Biol       Date:  2000

2.  Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.

Authors:  A Takada; S Watanabe; H Ito; K Okazaki; H Kida; Y Kawaoka
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

3.  Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.

Authors:  Gabriele Neumann; Heinz Feldmann; Shinji Watanabe; Igor Lukashevich; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.

Authors:  Graham Simmons; Rouven J Wool-Lewis; Frédéric Baribaud; Robert C Netter; Paul Bates
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.

Authors:  Z Y Yang; H J Duckers; N J Sullivan; A Sanchez; E G Nabel; G J Nabel
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

6.  Processing of the Ebola virus glycoprotein by the proprotein convertase furin.

Authors:  V E Volchkov; H Feldmann; V A Volchkova; H D Klenk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

7.  Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level.

Authors:  Nathalie Alazard-Dany; Valentina Volchkova; Olivier Reynard; Caroline Carbonnelle; Olga Dolnik; Michèle Ottmann; Alexander Khromykh; Viktor E Volchkov
Journal:  J Gen Virol       Date:  2006-05       Impact factor: 3.891

8.  Generation of biologically contained Ebola viruses.

Authors:  Peter Halfmann; Jin Hyun Kim; Hideki Ebihara; Takeshi Noda; Gabriele Neumann; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-22       Impact factor: 11.205

9.  Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor.

Authors:  Jeffrey E Lee; Marnie L Fusco; Ann J Hessell; Wendelien B Oswald; Dennis R Burton; Erica Ollmann Saphire
Journal:  Nature       Date:  2008-07-10       Impact factor: 49.962

10.  Antibody-dependent enhancement of Ebola virus infection.

Authors:  Ayato Takada; Heinz Feldmann; Thomas G Ksiazek; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  1 in total

1.  Efficient Expression and Processing of Ebola Virus Glycoprotein Induces Morphological Changes in BmN Cells but Cannot Rescue Deficiency of Bombyx Mori Nucleopolyhedrovirus GP64.

Authors:  Jinshan Huang; Na Liu; Fanbo Xu; Ellen Ayepa; Charles Amanze; Luping Sun; Yaqin Shen; Miao Yang; Shuwen Yang; Xingjia Shen; Bifang Hao
Journal:  Viruses       Date:  2019-11-15       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.